Thermo Fisher: The Rerating Is Just Getting Started - Buy

Group 1 - The stock is currently trading at 19x estimated EPS for 2026, indicating that the market valuation appears to be accurate based on Bloomberg consensus estimates [1] Group 2 - The analysis emphasizes a focus on macroeconomic factors, portfolio management, and equity research, highlighting the importance of economic cycles and monetary policy in investment strategies [1]